Tandem Diabetes Care (TNDM) insider buying

Healthcare · Medical Devices · Market cap $1.2B

8 open-market purchases of TNDM by Tandem Diabetes Care's executives and directors since August 2025, worth $251,711 in total, from SEC Form 4 filings.

The most recent: Gilbert Ray Cisneros, Jr. bought — on March 3, 2026.

The biggest buyer over the period is Leigh Vosseller: 1 purchase, $149,411.

By year

YearPurchasesValue
20263$0
20255$251,711

Biggest buyers

InsiderBuysValue
Leigh Vosseller
1$149,411
John F Sheridan
1$102,300
Gilbert Ray Cisneros, Jr.
3$0
Josh Gottheimer
3$0

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Mar 3, 2026 Gilbert Ray Cisneros, Jr.
0$23.74— —
Mar 3, 2026 Gilbert Ray Cisneros, Jr.
0$23.74— —
Mar 3, 2026 Gilbert Ray Cisneros, Jr.
0$23.74— —
Sep 22, 2025 Josh Gottheimer
0$13.06— —
Sep 22, 2025 Josh Gottheimer
0$13.06— —
Sep 22, 2025 Josh Gottheimer
0$13.06— —
Aug 11, 2025 John F Sheridan
10,000$10.23$102,300 Form 4
Aug 8, 2025 Leigh Vosseller
13,720$10.89$149,411 Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for TNDM.
Open TNDM in Investingly

Questions

Are Tandem Diabetes Care insiders buying the stock?

8 open-market purchases of TNDM by Tandem Diabetes Care's executives and directors since August 2025, worth $251,711 in total, from SEC Form 4 filings. The most recent: Gilbert Ray Cisneros, Jr. bought — on March 3, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Tandem Diabetes Care's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.